Edition:
United Kingdom

Biocartis Group NV (BCART.BR)

BCART.BR on Brussels Stock Exchange

11.24EUR
14 Dec 2018
Change (% chg)

€-0.20 (-1.75%)
Prev Close
€11.44
Open
€11.52
Day's High
€11.52
Day's Low
€11.18
Volume
26,409
Avg. Vol
68,973
52-wk High
€15.00
52-wk Low
€10.54

Select another date:

Thu, Nov 29 2018

Photo

Biocartis partners with AstraZeneca on lung cancer diagnostics

Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.

Biocartis partners with AstraZeneca on lung cancer diagnostics

Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.

Biocartis partners with AstraZeneca on lung cancer diagnostics

Nov 29 Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.

Select another date: